Apixaban
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='2p16' size='350' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban' scene='95/953982/Cv/1'> | <StructureSection load='2p16' size='350' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban' scene='95/953982/Cv/1'> | ||
| - | Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting | + | Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting [[Factor Xa]]. |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:08, 23 February 2023
| |||||||||||
